COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1537: Articles 15361-15370  | Next

Pediatric intensive care hybrid-style clinical round during COVID-19 pandemic: A pilot study
Temsah, M.-H., Alhaboob, A., Abouammoh, N., Al-Eyadhy, A., Aljamaan, F., Alsohime, F., Alabdulhafid, M., Ashry, A., Bukhari, A., Eltahir, O., Jamal, A., Halwani, R., Alhasan, K., Al-Tawfiq, J. A., Barry, M.
10.1101/2021.05.31.21258110 — Posted: 2021-06-01
The potential impact of vaccine passports on inclination to accept COVID-19 vaccinations in the United Kingdom: evidence from a large cross-sectional survey and modelling study
de Figueiredo, A., Larson, H. J., Reicher, S. D.
10.1101/2021.05.31.21258122 — Posted: 2021-06-01
Analysis of SARS-CoV-2 mutations reveals three types of temporal dynamics and one is correlated with international travels
Justo Arevalo, S., Zapata Sifuentes, D., Huallpa, C. J., Landa Bianchi, G., Castillo Chavez, A., Garavito-Salini Casas, R., Uribe Calampa, C. S., Uceda-Campos, G., Pineda Chavarria, R.
10.1101/2021.06.01.446571 — Posted: 2021-06-01 Discussion: Onsite
SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization
Jackson, L., Rodel, H., Hwa, S.-H., Cele, S., Ganga, Y., Tegally, H., Bernstein, M., Giandhari, J., COMMIT-KZN Team, , Gosnell, B. I., Khan, K., Hanekom, W., Karim, F., de Oliveira, T., Moosa, M.-Y. S., Sigal, A.
10.1101/2021.06.01.446516 — Posted: 2021-06-01
Virucidal activity of a proprietary blend of plant-based oils (Viruxal) against SARS-CoV-2 and influenza viruses - an in vitro study
Kristjansson, J. M., Rolfsson, O.
10.1101/2021.05.31.446420 — Posted: 2021-06-01
Synergistic inhibition of two host factors that facilitate entry of Severe Acute Respiratory Syndrome Coronavirus 2
Kreutzberger, A. J. B., Sanyal, A., Ojha, R., Pyle, J., Vapalahti, O., Balistreri, G., Kirchhausen, T.
10.1101/2021.06.01.446623 — Posted: 2021-06-01
Structural basis for SARS-CoV-2 Nucleocapsid protein recognition by single-domain antibodies
Ye, Q., Lu, S., Corbett, K. D.
10.1101/2021.06.01.446591 — Posted: 2021-06-01
Epidemiological profile study of COVID-19 in West African countries: Nigeria, Senegal, Mauritania, Cape Verde and Mali
Ba, M. F., Diop, B., Bassoum, O., Sougou, N. M., Niang, K., Bonnet, E., Ridde, V., Faye, A.
10.1101/2021.05.31.21258118 — Posted: 2021-06-01
Effect of 2021 Assembly Election in India on Covid-19 Transmission
Manik, S., Pal, S., Mandal, M., Hazra, M.
10.1101/2021.05.30.21258040 — Posted: 2021-06-01
Signatures of mast cell activation are associated with severe COVID-19
Tan, J., Anderson, D., Rathore, A. P. S., O'Neill, A., Mantri, C. K., Saron, W. A. A., Lee, C., Chu, W. C., Kang, A., Foo, R., Kalimuddin, S., Low, J., Ho, L., Tambyah, P., Burke, T. W., Woods, C. W., Chan, K. R., Karhausen, J., St John, A. L.
10.1101/2021.05.31.21255594 — Posted: 2021-06-01 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).